community-acquired

Moxifloxacin hydrochloride (BAY12-8039 HCl) 是一种口服有效的 8-甲氧基喹诺酮类抗菌药物，可研究感染性肺炎，急性细菌性鼻窦炎和慢性支气管炎的急性细菌性加重。

Omadacycline (Amadacycline) 是一种具有口服活性的氨基甲基环素抗菌剂，是四环素类抗生素。它与 30S 核糖体亚基结合，抑制细菌蛋白质合成。它可用于研究急性细菌性皮肤和皮肤结构感染，感染性肺炎和尿路感染。

Faropenem sodium 是一种口服生物可利用的青霉烯类抗生素，能有效杀灭结核分枝杆菌，治疗结核病和社区获得性肺炎。

Avarofloxacin (JNJ-Q2) is a broad-spectrum fluoroquinolone antibacterial drug being developed for the treatment of acute bacterial skin and community-acquired pneumonia and skin structure infections.

Decarboxy Moxifloxacin 是一种莫西沙星的脱羧化合物。Moxifloxacin 是一种能够口服的 8-甲氧基喹诺酮类抗菌药物，可用于急性细菌性鼻窦炎，慢性支气管炎的急性细菌性加重和感染性肺炎。

Lefamulin acetate (BC-3781 acetate) 是具有口服活性的抗生素。它是用于人体细菌感染的全身研究的半合成截短侧耳素。它与 50S 细菌核糖体的肽基转移酶peptidyl transferase 中心结合抑制蛋白质合成，并阻止了转移RNA 与肽转移的结合。

Nafithromycin (WCK 4873) 作为一种口服抗生素 (antibiotic)，主要用于治疗由肺炎链球菌、流感嗜血杆菌、卡他莫拉菌及Methicillin敏感金黄色葡萄球菌引发的社区获得性肺炎。该药物对于大环内酯耐药以及对Telithromycin不敏感的肺炎链球菌，具有较低的最小抑菌浓度（MIC90），仅为0.12 mg liter。

Cefdinir是一种先进的广谱头孢菌素类抗菌化合物，已被批准用于治疗成人和儿童患者的社区获得性肺炎、慢性支气管炎的急性细菌性加重、急性上颌窦炎、咽喉炎 扁桃体炎、急性细菌性中耳炎以及非并发性皮肤和皮肤结构感染。

Acorafloxacin is a broad-spectrum fluoroquinolone antibacterial drug being developed for the treatment of acute bacterial skin and skin structure infections and community-acquired pneumonia.

TP-271, a tetracyclines antibiotic, is used potentially for the treatment of community-acquired bacterial pneumonia (CABP).

Grepafloxacin (OPC-17116) is a fluoroquinolone antibiotic that is administered orally. It possesses strong efficacy against community-acquired respiratory pathogens, notably Streptococcus pneumonia. Grepafloxacin exhibits excellent tissue penetration and demonstrates a promising pharmacodynamic profile.

Lanopepden, also known as GSK-1322322 or GSK-322, is a potent and selective peptide deformylase inhibitor with good in vitro activity against bacteria associated with community-acquired pneumonia and skin infections. GSK1322322 had bactericidal activity against S. pneumoniae, H. influenzae, S. pyogenes, and S. aureus, demonstrating a ≥ 3-log(10) decrease in the number of CFU ml at 4× MIC within 24 h in 29 of the 33 strains tested. GSK1322322 represents a valuable alternative therapy for the treatment of infectious diseases caused by drug-resistant pathogens.

Omadacycline, also known as PTK 0796 and Amadacyclin, is a novel first-in-class aminomethylcycline with potent activity against important skin and pneumonia pathogens, including community-acquired methicillin-resistant Staphylococcus aureus (MRSA), β-hemolytic streptococci, penicillin-resistant Streptococcus pneumoniae, Haemophilus influenzae, and Legionella. Omadacycline is active against strains expressing the two main forms of tetracycline resistance (efflux and ribosomal protection). The primary effect of omadacycline is on bacterial protein synthesis, inhibiting protein synthesis with a potency greater than that of tetracycline. The binding site for omadacycline is similar to that for tetracycline.

Zifanocycline (KBP-7072) 为半合成第三代氨甲基环素类抗生素，通过抑制细菌核糖体功能而发挥作用。它对革兰氏阳性菌和革兰氏阴性菌[包括多重耐药病原体]显示出广泛的体外抗菌活性。适用于口服和注射形式，Zifanocycline 主要用于研究治疗急性细菌性皮肤及其结构感染、社区获得性细菌性肺炎以及复杂腹腔感染。

Ceftaroline fosamil hydrate acetate 是一种高效的头孢菌素类抗生素(antibiotic)，对多种病原体有广谱活性，特别是针对革兰氏阳性病原体，如耐甲氧西林金黄色葡萄球菌(MRSA)和耐多药肺炎链球菌，以及常见的革兰氏阴性微生物。此外，Ceftaroline fosamil hydrate acetate 在治疗复杂皮肤及皮肤结构感染(cSSSIs)和社区获得性肺炎(CABP)方面表现出显著的抗感染活性。

Nemonoxacin (TG-873870) 是一种可口服的非氟化喹诺酮类抗生素，具有广谱的抗菌活性，抑制葡萄球菌、链球菌和肠球菌、淋病奈瑟菌和流感嗜血杆菌均。Nemonoxacin 可用于研究细菌感染和社区获得性肺炎。

Cefetamet 是一种头孢类抗生素。Cefetamet 具有研究上、下社区获得性呼吸道感染的潜力。

Zifanocycline TFA (KBP-7072) 是一种半合成的氨基糖苷类抗生素，具有口服活性并能抑制细菌核糖体功能。它对广泛的革兰氏阳性菌和阴性菌示出了体外抗菌活性，包括多种耐药病原体。Zifanocycline TFA 适用于急性细菌性皮肤及皮肤结构感染、社区获得性细菌性肺炎和复杂的腹腔感染的研究。

Faropenem-d7 Sodium Salt 是 Faropenem Sodium Salt 的氘代化合物。Faropenem Sodium Salt 的 CAS 号为 122547-49-3。Faropenem sodium 是一种口服生物可利用的青霉烯类抗生素，能有效杀灭结核分枝杆菌，治疗结核病和社区获得性肺炎。